McIlrath & Eck’s Idexx Laboratories IDXX Stock Holding History

McIlrath & Eck’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81K	Hold	5	–	–	﹤0.01%	1367
2025 Q4	$3.38K	Buy	+5	New	+$3.4K	﹤0.01%	828

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

McIlrath & Eck's IDXX Position: Q1 2026 in Review

McIlrath & Eck held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 5 shares worth $2.81K. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

McIlrath & Eck first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.38K in Q4 2025. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

McIlrath & Eck held 5 shares of Idexx Laboratories worth $2.81K as of Q1 2026.
McIlrath & Eck left its Idexx Laboratories share count unchanged in Q1 2026.
Idexx Laboratories made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #1367 holding.
McIlrath & Eck first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
McIlrath & Eck's Idexx Laboratories position peaked at $3.38K in Q4 2025.
1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.